Fundraising Fox
Addimmune
Rockville, US · Founded 2023 · 1 employees on LinkedIn · 3 known investors
Find your way into Addimmune
Sign up to see every warm intro you have to Addimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Addimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.
Founders & leadership
BW
Barry WellsMD
Investors · 3
__Twitter.png)
Related companies · 1
Companies working in the same space as Addimmune.
In the news
Frequently asked questions
- What does Addimmune do?
- Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.
- Who are Addimmune's investors?
- Addimmune's investors include Gaingels, Ligo Partners LLC, Ossian Capital.
- Where is Addimmune headquartered?
- Addimmune is headquartered in Rockville, US.